financetom
Business
financetom
/
Business
/
Manufacturer Badger Meter beats Q2 revenue estimates on higher sales
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Manufacturer Badger Meter beats Q2 revenue estimates on higher sales
Jul 22, 2025 5:57 AM

Overview

* Badger Meter ( BMI ), which makes products to measure and control the flow of water, saw Q2 sales rise 10% yr/yr

* Diluted EPS for Q2 increases 4% to $1.17

* Utility water sales grow 11% yr/yr, driven by digital smart water solutions

Outlook

* Badger Meter ( BMI ) projects high single-digit revenue growth long-term

* Company sees favorable industry fundamentals supporting growth

* Badger Meter ( BMI ) expects SmartCover synergies to enhance future results

* Company continues to manage tariff impacts effectively

Result Drivers

* DIGITAL SOLUTIONS - Growth driven by increased adoption of digital smart water solutions, including metering and remote monitoring

* SMARTCOVER ACQUISITION - Utility water sales boosted by first full quarter of SmartCover acquisition

* FLOW INSTRUMENTATION - Sales flat as growth in water markets offset by declines in non-water applications

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Sales Beat $238.10 $236.90

mln mln (8

Analysts

)

Q2 EPS $1.17

Q2 Net $34.58

Income mln

Q2 $44.90

Operatin mln

g

Earnings

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the industrial machinery & equipment peer group is "buy"

* Wall Street's median 12-month price target for Badger Meter Inc ( BMI ) is $235.00, about 4.3% below its July 21 closing price of $245.22

* The stock recently traded at 46 times the next 12-month earnings vs. a P/E of 40 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
SunOpta to Expand Distribution of Dream Oakmilk Product to 6,700 Additional Stores in North America
SunOpta to Expand Distribution of Dream Oakmilk Product to 6,700 Additional Stores in North America
Oct 10, 2024
08:28 AM EDT, 10/09/2024 (MT Newswires) -- SunOpta ( STKL ) on Wednesday said that starting in January it will expand the distribution of its Dream Oatmilk Barista product to an additional 6,700 stores across North America. The expansion will be achieved through a partnership with a large coffee chain, SunOpta ( STKL ) said. ...
Biogen's Felzartamab Gets FDA Breakthrough Therapy Status in Kidney Transplant Rejection
Biogen's Felzartamab Gets FDA Breakthrough Therapy Status in Kidney Transplant Rejection
Oct 10, 2024
08:24 AM EDT, 10/09/2024 (MT Newswires) -- Biogen (BIIB) said Wednesday that its investigational drug felzartamab was granted breakthrough therapy designation by the US Food and Drug Administration to treat late antibody-mediated rejection without T-cell mediated rejection in kidney transplant patients. The company said it plans to initiate phase 3 trials in 2025 for felzartamab in antibody-mediated rejection as well...
CI Financial Partners with Neo Financial to Launch Suite of Financial Solutions
CI Financial Partners with Neo Financial to Launch Suite of Financial Solutions
Oct 10, 2024
08:29 AM EDT, 10/09/2024 (MT Newswires) -- CI Financial ( CIXXF ) said Wednesday that it partnered with Neo Financial to launch a new suite of everyday deposit and credit products. Under the partnership, CI Wealth clients will benefit from Neo's advanced technology, which offers streamlined applications and seamless, instant transfers between deposit and investment accounts, all within a single...
Market Chatter: UnitedHealth Group, CVS Seek Recusal of FTC Commissioners from Insulin Pricing Lawsuit
Market Chatter: UnitedHealth Group, CVS Seek Recusal of FTC Commissioners from Insulin Pricing Lawsuit
Oct 10, 2024
08:27 AM EDT, 10/09/2024 (MT Newswires) -- UnitedHealth Group ( UNH ) and CVS Health ( CVS ) are demanding Federal Trade Commission Chairwoman Lina Khan and two other commissioners recuse themselves from a lawsuit accusing the companies of increasing their profit while inflating insulin costs, CNBC reported Wednesday. The FTC filed a lawsuit against CVS Health's ( CVS )...
Copyright 2023-2025 - www.financetom.com All Rights Reserved